Alert: New Earnings Report (5/8/24)-Editas Medicine Inc (NASDAQ: EDIT).
For its first fiscal quarter (ending March 31), Editas Medicine Inc (NASDAQ: EDIT) has reported E.P.S. of $-0.76 compared to $-0.71 a year ago. This result fell short of the consensus estimate of $-0.63 by […]